Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy
暂无分享,去创建一个
D. Ehmann | A. Eakin | D. Nicolau | April Chen | R. Mclaughlin | Aryun Kim | Alita A. Miller | E. Gorseth | Kerry E. Murphy-Benenato | Asha S. Nayar | Sara A Patey | A. Tsai | A. Kutschke | M. Rooney | Christina M Blinn | Jared L. Crandon | Brian D. Dangel
[1] D. Nicolau,et al. Potentiation of Antibacterial Activity of the MB-1 Siderophore-Monobactam Conjugate Using an Efflux Pump Inhibitor , 2015, Antimicrobial Agents and Chemotherapy.
[2] I. Schalk,et al. Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa. , 2014, Metallomics : integrated biometal science.
[3] V. Shanmugasundaram,et al. Pyridone-conjugated monobactam antibiotics with gram-negative activity. , 2013, Journal of medicinal chemistry.
[4] D. Nicolau,et al. Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa , 2013, Antimicrobial Agents and Chemotherapy.
[5] T. Wencewicz,et al. Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii. , 2013, Journal of medicinal chemistry.
[6] M. Page,et al. Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli. , 2013, The Journal of antimicrobial chemotherapy.
[7] M. Page,et al. Involvement of Fe Uptake Systems and AmpC β-Lactamase in Susceptibility to the Siderophore Monosulfactam BAL30072 in Pseudomonas aeruginosa , 2013, Antimicrobial Agents and Chemotherapy.
[8] L. Aschenbrenner,et al. Clinically Relevant Gram-Negative Resistance Mechanisms Have No Effect on the Efficacy of MC-1, a Novel Siderophore-Conjugated Monocarbam , 2012, Antimicrobial Agents and Chemotherapy.
[9] T. Gootz,et al. Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols. , 2011, ACS medicinal chemistry letters.
[10] A. Skiada,et al. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa. , 2011, International journal of antimicrobial agents.
[11] R. Hancock,et al. Adaptive Resistance to the “Last Hope” Antibiotics Polymyxin B and Colistin in Pseudomonas aeruginosa Is Mediated by the Novel Two-Component Regulatory System ParR-ParS , 2010, Antimicrobial Agents and Chemotherapy.
[12] M. Page,et al. In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli , 2010, Antimicrobial Agents and Chemotherapy.
[13] Liesbeth M. M. van Oeffelen,et al. Iron uptake regulation in Pseudomonas aeruginosa , 2009, BioMetals.
[14] M. Marahiel,et al. Siderophore-Based Iron Acquisition and Pathogen Control , 2007, Microbiology and Molecular Biology Reviews.
[15] R. Bonomo,et al. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] W. Craig. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. , 2003, Infectious disease clinics of North America.
[17] D. Livermore. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Steven D. Brown,et al. In Vitro Activities of Daptomycin against 2,789 Clinical Isolates from 11 North American Medical Centers , 2001, Antimicrobial Agents and Chemotherapy.
[19] W. Craig,et al. In Vivo Activities of Amoxicillin and Amoxicillin-Clavulanate against Streptococcus pneumoniae: Application to Breakpoint Determinations , 1998, Antimicrobial Agents and Chemotherapy.
[20] P. Thornley,et al. Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis. , 1996, The Journal of antimicrobial chemotherapy.
[21] M. Vasil,et al. Role of the ferric uptake regulator of Pseudomonas aeruginosa in the regulation of siderophores and exotoxin A expression: purification and activity on iron-regulated promoters , 1995, Journal of bacteriology.
[22] C H Nightingale,et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients , 1995, Antimicrobial agents and chemotherapy.
[23] A. Barry,et al. In vitro susceptibility testing procedures for fosfomycin tromethamine , 1991, Antimicrobial Agents and Chemotherapy.
[24] G. Jackson,et al. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use , 1991, Antimicrobial Agents and Chemotherapy.
[25] V. Braun,et al. Novel two-component transmembrane transcription control: regulation of iron dicitrate transport in Escherichia coli K-12 , 1990, Journal of bacteriology.
[26] G. Jackson,et al. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. , 1990, The Journal of infectious diseases.
[27] H. Nikaido,et al. Cir and Fiu proteins in the outer membrane of Escherichia coli catalyze transport of monomeric catechols: study with beta-lactam antibiotics containing catechol and analogous groups , 1990, Journal of bacteriology.
[28] D. Haas,et al. Mapping of mutations affecting pyoverdine production in Pseudomonas aeruginosa , 1986 .
[29] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[30] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[31] W. Craig. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] R. Moore,et al. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. , 1987, The Journal of infectious diseases.